Rare Disease News

NORD and C-Path Release New Video, “RDCA-DAP: Shortening the Timeline for Developing New Treatments for Rare Diseases”

Published October 14, 2020 by NORD

Categorized in -

NORD and the Critical Path Institute (C-Path) are collaborating on a new initiative, the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), bringing together data from different sources, making it available for …

Continue reading “NORD and C-Path Release New Video, “RDCA-DAP: Shortening the Timeline for Developing New Treatments for Rare Diseases””

NORD and C-Path Release Video on Rare Disease Challenges in Each Step of the Drug Development Process

Published September 23, 2020 by NORD

Categorized in -

There are over 7,000 rare diseases, approximately 90% do not have FDA-approved treatments, and the process of developing therapies for rare diseases involves special challenges and considerations. NORD and the Critical Path Institute (C-Path) are working together …

Continue reading “NORD and C-Path Release Video on Rare Disease Challenges in Each Step of the Drug Development Process”

New Video Series on the 5 Steps of the Drug Development Process and How RDCA-DAP Can Help

Published August 27, 2020 by NORD

Categorized in -

There are five steps in the drug development process, which are designed to help ensure that potential new therapies are both safe and effective. Developing medical products for rare diseases encounters …

Continue reading “New Video Series on the 5 Steps of the Drug Development Process and How RDCA-DAP Can Help”

Rare Disease News

NORD and C-Path Release New Video, “RDCA-DAP: Shortening the Timeline for Developing New Treatments for Rare Diseases”

NORD and C-Path Release Video on Rare Disease Challenges in Each Step of the Drug Development Process

New Video Series on the 5 Steps of the Drug Development Process and How RDCA-DAP Can Help

Access State Report Card Data